Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 7, 2000, Pages 1990-1994

  Miltner, Elizabeth C ^a   Bermudez, Luiz E ^a  

^a Kuzell Institute for Arthritis and Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; RIFABUTIN;

ACANTHAMOEBA CASTELLANII; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DRUG EFFICACY; HOST; HUMAN; HUMAN CELL; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL;

ACANTHAMOEBA; ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLARITHROMYCIN; HT29 CELLS; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM; RIFABUTIN; U937 CELLS;

EID: 0033936494     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.7.1990-1994.2000     Document Type: Article

References (13)

1. Barker, J., M. R. Brown, P. J. Collier, I. Farrell, and P. Gilbert. 1992. Relationship between Legionella pneumophila and Acanthamoeba polyphaga: physiological status and susceptibility to chemical inactivation Appl. Environ. Microbiol. 58:2420-2425.
2. Barker, J., P. A. Lambert, and M. R. Brown. 1993. Influence of intraamoebic and other growth conditions on the surface properties of Legionella pneumophila. Infect. Immun. 61:3503-3510.
3. Barker, J., H. Scaife, and M. R. Brown. 1995. Intraphagocytic growth induces an antibiotic-resistant phenotype of Legionella pneumophila. Antimicrob. Agents Chemother. 39:2684-2688.
4. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Wu, L. Barbara-Burnham, and L. S. Young. 1996. Activities of Bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice. Antimicrob. Agents Chemother. 40:546-551.
5. Bermudez, L. E., M. Petrofsky, P. Kolonoski, and L. S. Young. 1992. An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract. J. Infect. Dis. 165:75-79.
6. Bermudez, L. E., and L. S. Young. 1988. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 140:3006-3013.
7. Cirillo, J. D., S. Falkow, and L. S. Tompkins. 1994. Growth of Legionella pneumophila in Acanthamoeba castellanii enhances invasion. Infect. Immun. 62:3254-3261.
8. Cirillo, J. D., S. Falkow, L. S. Tompkins, and L. E. Bermudez. 1997. Interaction of Mycobacterium avium with environmental amoebae enhances virulence. Infect. Immun. 65:3759-3767.
9. Damsker, B., and E. J. Bottone. 1985. Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: concepts regarding acquisition and pathogenesis. J. Infect. Dis. 51:179-181.
10. Falkinham, J. O., III. 1996. Molecular epidemiology techniques for the study of Mycobacterium avium complex infection, p. 23-44. In J. A. Korvick and C. A. Benson (ed.), Mycobacterium avium complex: progress in research and treatment. Marcel Dekker, Inc., New York, N.Y.
11. Horsburgh, C. R., Jr. 1991. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:1332-1338.
12. Inderlied, C. B., C. A. Kemper, and L. E. Bermudez. 1993. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:266-310.
13. Korvick, J., and C. Benson. 1996. Advances in the treatment and prophylaxis of Mycobacterium avium complex in individuals infected with human immunodeficiency virus, p. 241-262. In J. Korvick and C. Benson (ed.), Mycobacterium avium-complex: progress in research and treatment. Marcel Dekker, Inc., New York, N.Y.